You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

arginase inhibitor

Showing 1 - 25 of 7,393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Chuo Ku, Kashiwa (Retifanlimab, INCB001158, Retifanlimab + INCB001158)

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Chuo Ku, Japan
  • +1 more
Feb 24, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Type 1 Diabetes, Type 2 Diabetes Trial in Stockholm (N?-hydroxy-nor-arginine)

Recruiting
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Nω-hydroxy-nor-arginine
  • Stockholm, Sweden
    Karolinska Institutet
Apr 10, 2023

Obese, Endothelial Function Trial in Stockholm (N?-hydroxy-nor-arginine)

Completed
  • Obese
  • Endothelial Function
  • Stockholm, Sweden
    Karolinska Institutet, Karolinska University Hospital
Sep 7, 2022

Cystic Fibrosis Trial in Canada, United States (CB-280, Placebos)

Completed
  • Cystic Fibrosis
  • Little Rock, Arkansas
  • +19 more
Apr 11, 2022

Intestinal Biomarker Analysis After ECP for ICI Colitis

Recruiting
  • Colitis
  • Immune Checkpoint Inhibitor-Related Colitis
  • Intestinal tissue analysis
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Oct 5, 2023

Relapsed or Refractory Multiple Myeloma Trial in Germany, Spain, United States (INCB001158, Daratumumab SC)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Daphne, Alabama
  • +28 more
May 5, 2022

Squamous Cell Carcinoma Trial in Baltimore (Bavituximab, Pembrolizumab)

Recruiting
  • Squamous Cell Carcinoma
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 17, 2022

COPD, Dyspnea, Argininemia Trial in Milan (Arginine, Placebo)

Recruiting
  • COPD
  • +2 more
  • Milan, Italy
    L. Sacco Hospital
Jan 18, 2023

Type 1 Diabetes Trial in United States (DFMO, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • Aurora, Colorado
  • +5 more
Oct 21, 2022

Arginase I Deficiency, Hyperargininemia Trial (Pegzilarginase)

Not yet recruiting
  • Arginase I Deficiency
  • Hyperargininemia
  • (no location specified)
Jan 6, 2023

Arginase I Deficiency, Hyperargininemia Trial in Worldwide (AEB1102)

Active, not recruiting
  • Arginase I Deficiency
  • Hyperargininemia
  • Stanford, California
  • +6 more
Jul 22, 2022

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Cancer, Pediatric Solid Tumor, Pediatric AML Trial in Australia, United Kingdom (PEG- BCT-100)

Completed
  • Cancer
  • +3 more
  • PEG- BCT-100
  • Adelaide, Australia
  • +13 more
Sep 1, 2022

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023